Toxic shock syndrome differential diagnosis: Difference between revisions
Usama Talib (talk | contribs) |
No edit summary |
||
Line 34: | Line 34: | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Epidemiology}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Epidemiology}} | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Predisposing factors}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Predisposing factors}} | ||
! colspan="5" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Clinical features}}<ref name="pmid3069202">{{cite journal |vauthors=Todd JK |title=Toxic shock syndrome |journal=Clin. Microbiol. Rev. |volume=1 |issue=4 |pages=432–46 |year=1988 |pmid=3069202 |pmc=358064 |doi= |url=}}</ref><ref name="pmid264839892">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |year=2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url=}}</ref><ref name="pmid12720556">{{cite journal |vauthors=Sivagnanam S, Deleu D |title=Red man syndrome |journal=Crit Care |volume=7 |issue=2 |pages=119–20 |year=2003 |pmid=12720556 |pmc=270616 |doi= |url=}}</ref> | ! colspan="5" style="width: 200px; background: #4479BA; text-align: center;" | {{fontcolor|#FFF|Clinical features}}<ref name="pmid3069202">{{cite journal |vauthors=Todd JK |title=Toxic shock syndrome |journal=Clin. Microbiol. Rev. |volume=1 |issue=4 |pages=432–46 |year=1988 |pmid=3069202 |pmc=358064 |doi= |url=}}</ref><ref name="pmid264839892">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |year=2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url=}}</ref><ref name="pmid12720556">{{cite journal |vauthors=Sivagnanam S, Deleu D |title=Red man syndrome |journal=Crit Care |volume=7 |issue=2 |pages=119–20 |year=2003 |pmid=12720556 |pmc=270616 |doi= |url=}}</ref> | ||
! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Lab abnormalities'''}} | ! rowspan="2" style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Lab abnormalities'''}} | ||
|- | |- | ||
Line 40: | Line 40: | ||
| style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Symptoms'''}} | | style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|'''Symptoms'''}} | ||
|- | |- | ||
| rowspan="2" |Toxic shock syndrome | | rowspan="2" text-align: center;"|Toxic shock syndrome | ||
| rowspan="2" |Occurs in both adults and children (9:1 female predominance) | | rowspan="2" |Occurs in both adults and children (9:1 female predominance) | ||
| rowspan="2" | | | rowspan="2" text-align: center;"| | ||
* Occurs in association with [[vaginitis]] during [[menstruation]] following tampon use (S. aureus); | * Occurs in association with [[vaginitis]] during [[menstruation]] following tampon use (S. aureus); | ||
* As a complication of soft tissue infections ([[Streptococcus pyogenes|S. pyogenes]] or GAS) | * As a complication of soft tissue infections ([[Streptococcus pyogenes|S. pyogenes]] or GAS) | ||
Line 50: | Line 50: | ||
| text-align: center;"| '''[[Hypotension]]''' | | text-align: center;"| '''[[Hypotension]]''' | ||
| text-align: center;"| '''Diffuse [[Rash]]''' | | text-align: center;"| '''Diffuse [[Rash]]''' | ||
| text-align: center;"| '''Other signs''' | | text-align: center;" | '''Other signs''' | ||
| rowspan="2" | | | rowspan="2" text-align: center;"| | ||
* Diarrhea | * Diarrhea | ||
* Vomiting | * Vomiting | ||
Line 64: | Line 64: | ||
* [[Pyuria]] of [[renal]] origin.<ref name="pmid7282746">{{cite journal |vauthors=Chesney RW, Chesney PJ, Davis JP, Segar WE |title=Renal manifestations of the staphylococcal toxic-shock syndrome |journal=Am. J. Med. |volume=71 |issue=4 |pages=583–8 |year=1981 |pmid=7282746 |doi= |url=}}</ref> | * [[Pyuria]] of [[renal]] origin.<ref name="pmid7282746">{{cite journal |vauthors=Chesney RW, Chesney PJ, Davis JP, Segar WE |title=Renal manifestations of the staphylococcal toxic-shock syndrome |journal=Am. J. Med. |volume=71 |issue=4 |pages=583–8 |year=1981 |pmid=7282746 |doi= |url=}}</ref> | ||
|- | |- | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Nonpitting systemic [[edema]] | * Nonpitting systemic [[edema]] | ||
Line 78: | Line 78: | ||
* Close contact with a carrier | * Close contact with a carrier | ||
* Intimate kissing and cigarette smoking are associated with increased risk of meningococcal carriage<ref name="pmid16707051">{{cite journal |vauthors=MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM |title=Social behavior and meningococcal carriage in British teenagers |journal=Emerging Infect. Dis. |volume=12 |issue=6 |pages=950–7 |year=2006 |pmid=16707051 |pmc=3373034 |doi= |url=}}</ref> | * Intimate kissing and cigarette smoking are associated with increased risk of meningococcal carriage<ref name="pmid16707051">{{cite journal |vauthors=MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM |title=Social behavior and meningococcal carriage in British teenagers |journal=Emerging Infect. Dis. |volume=12 |issue=6 |pages=950–7 |year=2006 |pmid=16707051 |pmc=3373034 |doi= |url=}}</ref> | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Positive [[Kernig's sign]] | * Positive [[Kernig's sign]] | ||
Line 112: | Line 112: | ||
* [[Mycoplasma pneumoniae]] | * [[Mycoplasma pneumoniae]] | ||
* [[Herpes simplex virus]]<ref name="pmid211627212">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | * [[Herpes simplex virus]]<ref name="pmid211627212">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Positive Nikolsky sign (exerting mechanical pressure on several [[erythematous]] zones resluts in peeling of skin) | * Positive Nikolsky sign (exerting mechanical pressure on several [[erythematous]] zones resluts in peeling of skin) | ||
Line 141: | Line 141: | ||
* [[Nevirapine]] | * [[Nevirapine]] | ||
* [[Clindamycin]] | * [[Clindamycin]] | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Multi-organ dysfunction:<ref name="pmid19153346">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | * Multi-organ dysfunction:<ref name="pmid19153346">{{cite journal |vauthors=Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V |title=Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |journal=Arch Dermatol |volume=145 |issue=1 |pages=67–72 |year=2009 |pmid=19153346 |doi=10.1001/archderm.145.1.67 |url=}}</ref> | ||
Line 163: | Line 163: | ||
|- | |- | ||
|Redman syndrome | |Redman syndrome | ||
|Patients in whom | |Patients in whom the offending drug infusion is given over less than 1 hour and who are not pre-treated with diphenhydramine<ref name="pmid1955716">{{cite journal |vauthors=Wallace MR, Mascola JR, Oldfield EC |title=Red man syndrome: incidence, etiology, and prophylaxis |journal=J. Infect. Dis. |volume=164 |issue=6 |pages=1180–5 |year=1991 |pmid=1955716 |doi= |url=}}</ref> | ||
|Hypersensitivity to: | |Hypersensitivity to: | ||
* [[Vancomycin]] | * [[Vancomycin]] | ||
Line 170: | Line 170: | ||
* [[Rifampin|Rifampicin]] | * [[Rifampin|Rifampicin]] | ||
* [[Teicoplanin]] | * [[Teicoplanin]] | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
| | | | ||
Line 193: | Line 193: | ||
* Infection in combination with [[genetic predisposition]] to an [[autoimmune]] mechanism | * Infection in combination with [[genetic predisposition]] to an [[autoimmune]] mechanism | ||
([[Vasculitis|autoimmune vasculitis]]) | ([[Vasculitis|autoimmune vasculitis]]) | ||
| | | + | ||
| | | + | ||
| | | + | ||
| | | | ||
* Non-[[suppurative]], painless bilateral conjunctival [[inflammation]] ([[conjunctivitis]]) | * Non-[[suppurative]], painless bilateral conjunctival [[inflammation]] ([[conjunctivitis]]) | ||
Line 216: | Line 216: | ||
|Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | |Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | ||
|Occurs after streptococcal [[pharyngitis]]/[[tonsillitis]] | |Occurs after streptococcal [[pharyngitis]]/[[tonsillitis]] | ||
| | | + | ||
| | |<nowiki>+/-</nowiki> | ||
| | | + | ||
| | | | ||
* Pastia's sign (puncta and skin crease accentuation of the [[erythema]]) | * Pastia's sign (puncta and skin crease accentuation of the [[erythema]]) |
Revision as of 18:58, 31 May 2017
Toxic shock syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic shock syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Toxic shock syndrome differential diagnosis |
Risk calculators and risk factors for Toxic shock syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Toxic shock syndrome (TSS) may have a similar presentation to some diseases which present as a rash, fever and hypotension. Some features are unique to toxic shock syndrome and can be used to differentiate it from other diseases.
Differentiating Toxic Shock Syndrome from other Diseases
Toxic shock syndrome requires all 3 manifestations of fever, hypotension and diffuse scarlatiniform rash (innumerable small red papules that are diffusely distributed plus erythema, which blanches and desquamates one or two weeks after onset of illness). It presents with various signs of infection, hemodynamic dysfunction and organ failure.
Clinical presentation of fever, hypotension and rash must be differentiated from other diseases like:
Clinical presentation of fever and rash must be differentiated from other diseases like:
- Gram-negative sepsis
- Scarlet fever
- Viral exanthem
- Rickettsial disease
- Kawasaki disease
- Staphylococcal scalded skin syndrome
- Exfoliative erythroderma syndrome
- Erythema multiforme major
- Drug eruption
Common Differential Diagnoses in Patients with Fever and Rash
Disease | Epidemiology | Predisposing factors | Clinical features[1][2][3] | Lab abnormalities | ||||
---|---|---|---|---|---|---|---|---|
Signs | Symptoms | |||||||
Toxic shock syndrome | Occurs in both adults and children (9:1 female predominance) |
(C. sordellii). |
Fever | Hypotension | Diffuse Rash | Other signs |
|
|
+ | + | + |
| |||||
Meningococcemia | Occurs in young adults living in close proximity (college dorms, military recruits)[8] |
|
+ | + | + |
|
| |
Steven Johnson syndrome (SJS) | HLA-B*1502 gene leads to increased susceptibility[13] | Triggered by certain medications, most commonly: | + | + | + |
|
| |
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome | + | + | + |
|
|
| ||
Redman syndrome | Patients in whom the offending drug infusion is given over less than 1 hour and who are not pre-treated with diphenhydramine[23] | Hypersensitivity to: | + | + | + |
|
No elevation in tryptase levels indicating that it is an anaphylactoid reaction[24] | |
Kawasaki | Occurs in children, usually age 1-4 years |
|
+ | + | + |
|
|
|
Scarlet fever | Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | Occurs after streptococcal pharyngitis/tonsillitis | + | +/- | + |
|
Rash:
|
|
Less common Differential Diagnoses in Patients with Fever and Rash
Disease | Features |
---|---|
Impetigo | |
Insect bites |
|
Kawasaki disease |
|
Measles |
|
Monkeypox |
|
Rubella |
|
Atypical measles |
|
Coxsackievirus |
|
Acne |
|
Syphilis | It commonly presents with gneralized systemic symptoms such as malaise, fatigue, headache and fever. Skin eruptions may be subtle and asymptomatic It is classically described as:
|
Molluscum contagiosum |
|
Mononucleosis |
|
Toxic erythema | |
Rat-bite fever | |
Parvovirus B19 | |
Cytomegalovirus |
|
Scarlet fever |
|
Rocky Mountain spotted fever |
|
Stevens-Johnson syndrome |
|
Varicella-zoster virus | |
Chickenpox |
|
Meningococcemia |
|
Rickettsial pox | |
Meningitis |
|
References
- ↑ Todd JK (1988). "Toxic shock syndrome". Clin. Microbiol. Rev. 1 (4): 432–46. PMC 358064. PMID 3069202.
- ↑ Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ Sivagnanam S, Deleu D (2003). "Red man syndrome". Crit Care. 7 (2): 119–20. PMC 270616. PMID 12720556.
- ↑ Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ Brook MG, Bannister BA (1988). "Scarlet fever can mimic toxic shock syndrome". Postgrad Med J. 64 (758): 965–7. PMC 2429080. PMID 3256819.
- ↑ Minemura M, Tajiri K, Shimizu Y (2014). "Liver involvement in systemic infection". World J Hepatol. 6 (9): 632–42. doi:10.4254/wjh.v6.i9.632. PMC 4179142. PMID 25276279.
- ↑ Chesney RW, Chesney PJ, Davis JP, Segar WE (1981). "Renal manifestations of the staphylococcal toxic-shock syndrome". Am. J. Med. 71 (4): 583–8. PMID 7282746.
- ↑ Harrison LH (2010). "Epidemiological profile of meningococcal disease in the United States". Clin. Infect. Dis. 50 Suppl 2: S37–44. doi:10.1086/648963. PMC 2820831. PMID 20144015.
- ↑ MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM (2006). "Social behavior and meningococcal carriage in British teenagers". Emerging Infect. Dis. 12 (6): 950–7. PMC 3373034. PMID 16707051.
- ↑ WARTENBERG R (1950). "The signs of Brudzinski and of Kernig". J. Pediatr. 37 (4): 679–84. PMID 14779273.
- ↑ Bush LM (2014). "Case 28-2014: A man with a rash, headache, fever, nausea, and photophobia". N. Engl. J. Med. 371 (23): 2238–9. doi:10.1056/NEJMc1412237#SA2. PMID 25470712.
- ↑ 12.0 12.1 "Meningitis Symptoms - Meningitis Research Foundation".
- ↑ Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004). "Medical genetics: a marker for Stevens-Johnson syndrome". Nature. 428 (6982): 486. doi:10.1038/428486a. PMID 15057820.
- ↑ Techasatian L, Panombualert S, Uppala R, Jetsrisuparb C (2016). "Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital". World J Pediatr. doi:10.1007/s12519-016-0057-3. PMID 27650525.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM (2007). "Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management". Cornea. 26 (2): 123–9. doi:10.1097/ICO.0b013e31802eb264. PMID 17251797.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Choudhary S, McLeod M, Torchia D, Romanelli P (2013). "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome". J Clin Aesthet Dermatol. 6 (6): 31–7. PMC 3718748. PMID 23882307.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D (2006). "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?". Br. J. Dermatol. 155 (2): 422–8. doi:10.1111/j.1365-2133.2006.07284.x. PMID 16882184.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Wallace MR, Mascola JR, Oldfield EC (1991). "Red man syndrome: incidence, etiology, and prophylaxis". J. Infect. Dis. 164 (6): 1180–5. PMID 1955716.
- ↑ Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J (1998). "Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions". Anesthesiology. 89 (3): 620–5. PMID 9743397.
- ↑ Lin YJ, Cheng MC, Lo MH, Chien SJ (2015). "Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit". Pediatr. Infect. Dis. J. 34 (11): 1163–7. doi:10.1097/INF.0000000000000852. PMID 26222065.